STOCK TITAN

Proshares Morningstar Alts Solu (ALTS) Stock News

ALTS Nasdaq

Welcome to our dedicated page for Proshares Morningstar Alts Solu news (Ticker: ALTS), a resource for investors and traders seeking the latest updates and insights on Proshares Morningstar Alts Solu stock.

ALT5 Sigma Corporation (NASDAQ: ALTS) is a fintech company that focuses on digital asset payments, trading, settlement infrastructure, and a large $WLFI digital asset treasury position. News about ALT5 often centers on its institutional-grade platforms, ALT5 Pay and ALT5 Prime, which the company reports have processed billions of dollars in cryptocurrency and digital asset transactions since their inception in 2018.

Investors and observers following ALTS news will find updates on transaction volumes across its payments and settlement infrastructure, developments in its $WLFI Treasury strategy, and progress integrating the USD1 stablecoin into its platforms. Company announcements have highlighted record annual transaction volumes, multi-year growth in processed transactions, and the role of ALT5’s infrastructure in supporting card-based programs that enable crypto-to-fiat and fiat-to-crypto spending.

ALT5 Sigma’s news flow also includes disclosures related to its strategic relationship with World Liberty Financial, Inc., including its position as a leading holder of $WLFI, the governance token of the USD1 ecosystem. Press releases describe how USD1 adoption and $WLFI ecosystem developments may relate to the company’s treasury strategy and payments roadmap. In addition, corporate updates cover governance and regulatory topics such as Nasdaq listing compliance, executive leadership changes, auditor appointments, and settlements of legal matters.

For those tracking ALTS, this news page aggregates company press releases and related coverage, providing a view into how ALT5 manages its fintech operations, digital asset treasury, and legacy biotechnology segment over time. Readers can use the news feed to monitor operational milestones, regulatory filings referenced in announcements, and strategic developments across the company’s payments and digital asset ecosystem.

Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) has announced its participation in the upcoming iFX EXPO Dubai at the Dubai World Trade Centre from January 14-16, 2025. The company will showcase at booth #26, offering product demonstrations and solutions to over 7,000 expected attendees.

ALT5 Sigma, a fintech company listed on Nasdaq and part of the Russell Microcap Index, provides blockchain-powered technologies for digital assets. Through its subsidiary ALT5 Sigma Inc., the company operates two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform. The company processed over US$1.2 billion in cryptocurrency transactions in 2023.

The company also maintains biotech activities focused on developing solutions to address the opioid crisis, with drugs in clinical trials targeting pain management alternatives to addictive opioids.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
none
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) announced the approval of all proposed resolutions at its 2024 AGM, including the re-election of board members and the election of CEO Peter Tassiopoulos to the Board. The company reported achieving record transaction volumes exceeding US$2 billion in 2024 through its ALT5 Pay and Prime platforms.

The company plans to spin-off its healthcare assets into Alyea Therapeutics in the first half of 2025. Alyea has executed a non-binding LOI to acquire Soin Bioscience , which would bring innovative clear patch pain medication technology to its portfolio. The global pain patch market is projected to grow from US$4.80 billion in 2021 to US$7.33 billion by 2031.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
none
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) reported strong Q3 2024 financial results with record revenue of $4.94 million and gross profit of $2.39 million in its fintech segment. The company achieved a fintech net income of $714k and Adjusted EBITDA of $889k. Cash and equivalents stood at $8.67 million. The company plans to separate its biotech business, Alyea Therapeutics, in the first half of 2025, with intentions to finance Alyea's operations separately. Transaction volume exceeded $600 million for Q3. The company recently acquired additional IP to enhance features planned for Q4 and fiscal 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.6%
Tags
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) has appointed Ron Pitters to its Board of Directors. Pitters, currently serving as CAO of Axos Clearing and President of Axos Business Center Corp., brings over 20 years of experience in fintech, financial services, and emerging technologies. His global business management experience spans Asia, the Middle East, Europe, and the USA.

ALT5 Sigma, a fintech innovator providing blockchain-powered technologies, processed over US$1.2 billion in cryptocurrency transactions in 2023 through its platforms ALT5 Pay and ALT5 Prime. The company is also developing innovative solutions for the opioid crisis through its biotech division.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.65%
Tags
management
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) announces its participation in Spartan Capital Securities' inaugural investor conference scheduled for November 4th at the Pierre Hotel in New York. The event will feature presentations from over 30 selected companies, including panel discussions, one-on-one meetings, and networking sessions. The conference, organized in partnership with B2i Digital, aims to facilitate interactions between companies and Spartan Capital's investor base. ALT5's CRO Vay Tham will present the company's growth strategy and market position to key capital market influencers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
none
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) announced its participation in the upcoming Money20/20 Las Vegas conference from October 27-30, 2024. The company will exhibit at booth #11713 at The Venetian Resort, providing product demonstrations and solutions to over 12,000 attendees. Money20/20 USA is the largest gathering of the global money ecosystem, including banks, payments, tech, startups, and fintech. ALT5 Sigma's CRO Vay Tham highlighted the company's growing volumes in crypto payments, positioning them as an innovator in the payments ecosystem.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.3%
Tags
none
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) reported a record transaction volume of over $240 million for September 2024, representing a 151% year-over-year increase from September 2023. The company's year-to-date transaction volume reached approximately $1.5 billion, with Q3 exceeding $600 million, marking a record quarter. ALT5 Sigma, a fintech company providing blockchain-powered technologies for digital asset services, attributes this growth to realigned sales and marketing efforts, global tradeshow presence, new customer onboardings, and increased flows from existing customers.

The company offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform for digital assets. In 2023, ALT5 Sigma processed over $1.2 billion in cryptocurrency transactions. The company is also involved in biotech activities, focusing on developing innovative solutions to address the opioid crisis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS) has announced a strategic plan to separate into two independent publicly traded companies. The separation will result in ALT5 continuing as a leading fintech organization, while the Biotech segment will become Alyea Therapeutics , focusing on non-addictive pain management therapies.

Key benefits of the separation include:

  • Increased focus and agility within respective industries
  • Tailored capital allocation strategies
  • Enhanced strategic flexibility for M&A
  • Unique investment profiles for diverse investor bases
  • Distinct boards and management teams

ALT5 will maintain its focus on blockchain-powered technologies, offering ALT5 Pay and ALT5 Prime platforms. Alyea Therapeutics will develop non-addictive pain management therapies, with its lead candidate JAN123 receiving FDA orphan drug designation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
none
-
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS), a fintech company specializing in blockchain-powered technologies for digital asset management, has reported impressive growth in its transaction volume. For August 2024, the company's transaction volume reached US$192 million, marking a 120% year-over-year increase from August 2023's $87 million. The year-to-date transaction volume for the first eight months of 2024 stands at US$1.250 billion, representing a 104% year-over-year increase. This substantial growth demonstrates ALT5's strong performance in the digital asset space and its ability to capitalize on the increasing demand for blockchain-based financial solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
none
Rhea-AI Summary

ALT5 Sigma (NASDAQ:ALTS), a fintech company specializing in blockchain-powered technologies for digital asset management, has announced its participation in the upcoming iFX Bangkok Expo. The event, scheduled for September 16-18, 2024, will be held at the Centra Grand & Bangkok Convention Centre. ALT5 will be exhibiting at booth #88 throughout the three-day show, offering product demonstrations and information to over 4,500 attendees.

Vay Tham, CRO of ALT5 Sigma, emphasized the importance of iFX Expo Asia as the leading online trading event and an excellent platform to showcase ALT5 Prime, their electronic over-the-counter trading platform for digital assets. The company's participation aligns with its global expansion plans and efforts to grow its customer base worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none

FAQ

What is the current stock price of Proshares Morningstar Alts Solu (ALTS)?

The current stock price of Proshares Morningstar Alts Solu (ALTS) is $0.855 as of April 29, 2026.

What is the market cap of Proshares Morningstar Alts Solu (ALTS)?

The market cap of Proshares Morningstar Alts Solu (ALTS) is approximately 119.6M.